Nevada’s new opioid regulations on hold amid further study by state board
The Nevada Board of Medical Examiners has published extensive information and fact sheets — both for practitioners, as well as patients and consumers — on its website. Visit medboard.nv.gov/Resources/ControlledSubstancePrescribing to learn more.
CARSON CITY, Nev. — It will take several months of workshops to iron out regulations with the state of Nevada’s new controls over opioid drug prescriptions.
The Nevada Board of Medical Examiners issued a statement Jan. 11 saying a public workshop on the proposed disciplinary regulations revealed considerable confusion about how to implement Assembly Bill 474’s mandates — including, potentially, negative impacts on patients as well as medical practitioners.
According to the statement, the board is forming a working group to study how the mandates of AB474 (which was approved by the state legislature in 2017) will impact all those involved. The group will include at least two medical board members, a representative from the legislature, representatives from the state Medical association as well as industry stakeholders.
Their goal, according to the board, will be to produce a draft regulation that meets the intent of AB474 while serving the needs of patients and support licensees in their medical practices.
Once approved, the proposed regulations will be submitted to the full board of medical examiners, which will then begin the formal approval process through the Nevada legislative committee that reviews regulations.
AB474 is designed to get a better handle on the state’s opioid addiction and overdose crisis by putting controls in place over prescribing practices, including requiring treatment plans that move patients off of the extremely addictive drugs.
It limits new patients to a 14-day initial prescription for opioids and says without valid cause, no patient should be on those drugs for more than a year.
It also requires much more extensive discussions with patients about the use, dangers and potential abuse of opioid drugs.
In addition, it mandates much more extensive reporting of who’s prescribing the drugs and how much practitioners are prescribing and builds an extensive database to prevent patients from doctor shopping to get multiple prescriptions from several doctors as well as identify doctors prescribing to much of those drugs.
Support Local Journalism
Support Local Journalism
Readers around Lake Tahoe, Truckee, and beyond make the Sierra Sun's work possible. Your financial contribution supports our efforts to deliver quality, locally relevant journalism.
Now more than ever, your support is critical to help us keep our community informed about the evolving coronavirus pandemic and the impact it is having locally. Every contribution, however large or small, will make a difference.
Your donation will help us continue to cover COVID-19 and our other vital local news.
Start a dialogue, stay on topic and be civil.
If you don't follow the rules, your comment may be deleted.
User Legend: Moderator Trusted User
With the economy in California opened back up, businesses throughout the region are finding it difficult to attract employees.